Brief: Ambu Narrows Organic Revenue Growth Guidance Based On Q3, Q4 Performance

Ambu A/S

31/08/2023 06:09

Aug 31 (Reuters) - Ambu A/S  AMBUb.CO :
    * INTERIM REPORT FOR Q3 2022/23
    * Q3 PERFORMANCE REFLECTED BY 23% GROWTH IN ENDOSCOPY
SOLUTIONS
AND 16% IN PULMONOLOGY
    * NARROWS FULL-YEAR 2022/23 ORGANIC REVENUE GROWTH GUIDANCE
BASED
ON PERFORMANCE IN Q3 AND FIRST TWO MONTHS OF Q4

Source text for Eikon:  ID:nGNE9hbNMS 
Further company coverage:  AMBUb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))